Evidence review and recommendations for the implementation of genomics for antimicrobial resistance surveillance: reports from an international expert group
Nearly a century after the beginning of the antibiotic era, which has been associated with unparalleled improvements in human health and reductions in mortality associated with infection, the dwindling pipeline for new antibiotic classes coupled with the inevitable spread of antimicrobial resistance...
Gespeichert in:
Veröffentlicht in: | The Lancet. Microbe 2023-12, Vol.4 (12), p.e1035-e1039 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e1039 |
---|---|
container_issue | 12 |
container_start_page | e1035 |
container_title | The Lancet. Microbe |
container_volume | 4 |
creator | Baker, Kate S Jauneikaite, Elita Nunn, Jamie G Midega, Janet T Atun, Rifat Holt, Kathryn E Walia, Kamini Howden, Benjamin P Tate, Heather Okeke, Iruka N Carattoli, Alessandra Hsu, Li Yang Hopkins, Katie L Muloi, Dishon M Wheeler, Nicole E Aanensen, David M Mason, Lewis C E Rodgus, Jonah Hendriksen, Rene S Essack, Sabiha Y Egyir, Beverly Halpin, Alison L MacCannell, Duncan R Campos, Josefina Srikantiah, Padmini Feasey, Nicholas A Peacock, Sharon J |
description | Nearly a century after the beginning of the antibiotic era, which has been associated with unparalleled improvements in human health and reductions in mortality associated with infection, the dwindling pipeline for new antibiotic classes coupled with the inevitable spread of antimicrobial resistance (AMR) poses a major global challenge. Historically, surveillance of bacteria with AMR typically relied on phenotypic analysis of isolates taken from infected individuals, which provides only a low-resolution view of the epidemiology behind an individual infection or wider outbreak. Recent years have seen increasing adoption of powerful new genomic technologies with the potential to revolutionise AMR surveillance by providing a high-resolution picture of the AMR profile of the bacteria causing infections and providing real-time actionable information for treating and preventing infection. However, many barriers remain to be overcome before genomic technologies can be adopted as a standard part of routine AMR surveillance around the world. Accordingly, the Surveillance and Epidemiology of Drug-resistant Infections Consortium convened an expert working group to assess the benefits and challenges of using genomics for AMR surveillance. In this Series, we detail these discussions and provide recommendations from the working group that can help to realise the massive potential benefits for genomics in surveillance of AMR. |
doi_str_mv | 10.1016/S2666-5247(23)00281-1 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2891759320</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2891759320</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-a6de82f205a61324d351962d055ce70aab967e6d4d38cc762889e46884162c653</originalsourceid><addsrcrecordid>eNpNUctOxCAUJUajRv0EDUtdVHkU2rozZnwkk7hQ14ShtyOmLRXoqP_ix0pn1Lji3nPPORc4CB1Tck4JlRePTEqZCZYXp4yfEcJKmtEttP8Hb_-r99BRCK8ksQRlVIhdtMeLqiiozPfR12xla-gNYA8rC-9Y93Uqjes66GsdresDbpzH8QWw7YYWEh7XOHYNXkLvOms2FN1HmxrvFla3ySTYEPVkHUa_Atu2U3OZBoPzMUm865IG2z6C79eWSQYfA_iIl96NwyHaaXQb4OjnPEDPN7On67ts_nB7f301zwwXMmZa1lCyhhGhJeUsr7mglWQ1EcJAQbReVLIAWadBaUwhWVlWkMuyzKlkRgp-gE43voN3byOEqDobDEwXBjcGxcqKFqLijCSq2FDTM0Pw0KjB2077T0WJmrJR62zU9PGKcbXORtGkO_lZMS46qP9Uv0nwb34Vjdc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2891759320</pqid></control><display><type>article</type><title>Evidence review and recommendations for the implementation of genomics for antimicrobial resistance surveillance: reports from an international expert group</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Baker, Kate S ; Jauneikaite, Elita ; Nunn, Jamie G ; Midega, Janet T ; Atun, Rifat ; Holt, Kathryn E ; Walia, Kamini ; Howden, Benjamin P ; Tate, Heather ; Okeke, Iruka N ; Carattoli, Alessandra ; Hsu, Li Yang ; Hopkins, Katie L ; Muloi, Dishon M ; Wheeler, Nicole E ; Aanensen, David M ; Mason, Lewis C E ; Rodgus, Jonah ; Hendriksen, Rene S ; Essack, Sabiha Y ; Egyir, Beverly ; Halpin, Alison L ; MacCannell, Duncan R ; Campos, Josefina ; Srikantiah, Padmini ; Feasey, Nicholas A ; Peacock, Sharon J</creator><creatorcontrib>Baker, Kate S ; Jauneikaite, Elita ; Nunn, Jamie G ; Midega, Janet T ; Atun, Rifat ; Holt, Kathryn E ; Walia, Kamini ; Howden, Benjamin P ; Tate, Heather ; Okeke, Iruka N ; Carattoli, Alessandra ; Hsu, Li Yang ; Hopkins, Katie L ; Muloi, Dishon M ; Wheeler, Nicole E ; Aanensen, David M ; Mason, Lewis C E ; Rodgus, Jonah ; Hendriksen, Rene S ; Essack, Sabiha Y ; Egyir, Beverly ; Halpin, Alison L ; MacCannell, Duncan R ; Campos, Josefina ; Srikantiah, Padmini ; Feasey, Nicholas A ; Peacock, Sharon J ; SEDRIC Genomics Surveillance Working Group</creatorcontrib><description>Nearly a century after the beginning of the antibiotic era, which has been associated with unparalleled improvements in human health and reductions in mortality associated with infection, the dwindling pipeline for new antibiotic classes coupled with the inevitable spread of antimicrobial resistance (AMR) poses a major global challenge. Historically, surveillance of bacteria with AMR typically relied on phenotypic analysis of isolates taken from infected individuals, which provides only a low-resolution view of the epidemiology behind an individual infection or wider outbreak. Recent years have seen increasing adoption of powerful new genomic technologies with the potential to revolutionise AMR surveillance by providing a high-resolution picture of the AMR profile of the bacteria causing infections and providing real-time actionable information for treating and preventing infection. However, many barriers remain to be overcome before genomic technologies can be adopted as a standard part of routine AMR surveillance around the world. Accordingly, the Surveillance and Epidemiology of Drug-resistant Infections Consortium convened an expert working group to assess the benefits and challenges of using genomics for AMR surveillance. In this Series, we detail these discussions and provide recommendations from the working group that can help to realise the massive potential benefits for genomics in surveillance of AMR.</description><identifier>ISSN: 2666-5247</identifier><identifier>EISSN: 2666-5247</identifier><identifier>DOI: 10.1016/S2666-5247(23)00281-1</identifier><identifier>PMID: 37977164</identifier><language>eng</language><publisher>England</publisher><subject>Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Anti-Infective Agents ; Bacterial Infections - drug therapy ; Drug Resistance, Bacterial - genetics ; Genomics ; Humans</subject><ispartof>The Lancet. Microbe, 2023-12, Vol.4 (12), p.e1035-e1039</ispartof><rights>Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-a6de82f205a61324d351962d055ce70aab967e6d4d38cc762889e46884162c653</citedby><cites>FETCH-LOGICAL-c356t-a6de82f205a61324d351962d055ce70aab967e6d4d38cc762889e46884162c653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37977164$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baker, Kate S</creatorcontrib><creatorcontrib>Jauneikaite, Elita</creatorcontrib><creatorcontrib>Nunn, Jamie G</creatorcontrib><creatorcontrib>Midega, Janet T</creatorcontrib><creatorcontrib>Atun, Rifat</creatorcontrib><creatorcontrib>Holt, Kathryn E</creatorcontrib><creatorcontrib>Walia, Kamini</creatorcontrib><creatorcontrib>Howden, Benjamin P</creatorcontrib><creatorcontrib>Tate, Heather</creatorcontrib><creatorcontrib>Okeke, Iruka N</creatorcontrib><creatorcontrib>Carattoli, Alessandra</creatorcontrib><creatorcontrib>Hsu, Li Yang</creatorcontrib><creatorcontrib>Hopkins, Katie L</creatorcontrib><creatorcontrib>Muloi, Dishon M</creatorcontrib><creatorcontrib>Wheeler, Nicole E</creatorcontrib><creatorcontrib>Aanensen, David M</creatorcontrib><creatorcontrib>Mason, Lewis C E</creatorcontrib><creatorcontrib>Rodgus, Jonah</creatorcontrib><creatorcontrib>Hendriksen, Rene S</creatorcontrib><creatorcontrib>Essack, Sabiha Y</creatorcontrib><creatorcontrib>Egyir, Beverly</creatorcontrib><creatorcontrib>Halpin, Alison L</creatorcontrib><creatorcontrib>MacCannell, Duncan R</creatorcontrib><creatorcontrib>Campos, Josefina</creatorcontrib><creatorcontrib>Srikantiah, Padmini</creatorcontrib><creatorcontrib>Feasey, Nicholas A</creatorcontrib><creatorcontrib>Peacock, Sharon J</creatorcontrib><creatorcontrib>SEDRIC Genomics Surveillance Working Group</creatorcontrib><title>Evidence review and recommendations for the implementation of genomics for antimicrobial resistance surveillance: reports from an international expert group</title><title>The Lancet. Microbe</title><addtitle>Lancet Microbe</addtitle><description>Nearly a century after the beginning of the antibiotic era, which has been associated with unparalleled improvements in human health and reductions in mortality associated with infection, the dwindling pipeline for new antibiotic classes coupled with the inevitable spread of antimicrobial resistance (AMR) poses a major global challenge. Historically, surveillance of bacteria with AMR typically relied on phenotypic analysis of isolates taken from infected individuals, which provides only a low-resolution view of the epidemiology behind an individual infection or wider outbreak. Recent years have seen increasing adoption of powerful new genomic technologies with the potential to revolutionise AMR surveillance by providing a high-resolution picture of the AMR profile of the bacteria causing infections and providing real-time actionable information for treating and preventing infection. However, many barriers remain to be overcome before genomic technologies can be adopted as a standard part of routine AMR surveillance around the world. Accordingly, the Surveillance and Epidemiology of Drug-resistant Infections Consortium convened an expert working group to assess the benefits and challenges of using genomics for AMR surveillance. In this Series, we detail these discussions and provide recommendations from the working group that can help to realise the massive potential benefits for genomics in surveillance of AMR.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Anti-Infective Agents</subject><subject>Bacterial Infections - drug therapy</subject><subject>Drug Resistance, Bacterial - genetics</subject><subject>Genomics</subject><subject>Humans</subject><issn>2666-5247</issn><issn>2666-5247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNUctOxCAUJUajRv0EDUtdVHkU2rozZnwkk7hQ14ShtyOmLRXoqP_ix0pn1Lji3nPPORc4CB1Tck4JlRePTEqZCZYXp4yfEcJKmtEttP8Hb_-r99BRCK8ksQRlVIhdtMeLqiiozPfR12xla-gNYA8rC-9Y93Uqjes66GsdresDbpzH8QWw7YYWEh7XOHYNXkLvOms2FN1HmxrvFla3ySTYEPVkHUa_Atu2U3OZBoPzMUm865IG2z6C79eWSQYfA_iIl96NwyHaaXQb4OjnPEDPN7On67ts_nB7f301zwwXMmZa1lCyhhGhJeUsr7mglWQ1EcJAQbReVLIAWadBaUwhWVlWkMuyzKlkRgp-gE43voN3byOEqDobDEwXBjcGxcqKFqLijCSq2FDTM0Pw0KjB2077T0WJmrJR62zU9PGKcbXORtGkO_lZMS46qP9Uv0nwb34Vjdc</recordid><startdate>202312</startdate><enddate>202312</enddate><creator>Baker, Kate S</creator><creator>Jauneikaite, Elita</creator><creator>Nunn, Jamie G</creator><creator>Midega, Janet T</creator><creator>Atun, Rifat</creator><creator>Holt, Kathryn E</creator><creator>Walia, Kamini</creator><creator>Howden, Benjamin P</creator><creator>Tate, Heather</creator><creator>Okeke, Iruka N</creator><creator>Carattoli, Alessandra</creator><creator>Hsu, Li Yang</creator><creator>Hopkins, Katie L</creator><creator>Muloi, Dishon M</creator><creator>Wheeler, Nicole E</creator><creator>Aanensen, David M</creator><creator>Mason, Lewis C E</creator><creator>Rodgus, Jonah</creator><creator>Hendriksen, Rene S</creator><creator>Essack, Sabiha Y</creator><creator>Egyir, Beverly</creator><creator>Halpin, Alison L</creator><creator>MacCannell, Duncan R</creator><creator>Campos, Josefina</creator><creator>Srikantiah, Padmini</creator><creator>Feasey, Nicholas A</creator><creator>Peacock, Sharon J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202312</creationdate><title>Evidence review and recommendations for the implementation of genomics for antimicrobial resistance surveillance: reports from an international expert group</title><author>Baker, Kate S ; Jauneikaite, Elita ; Nunn, Jamie G ; Midega, Janet T ; Atun, Rifat ; Holt, Kathryn E ; Walia, Kamini ; Howden, Benjamin P ; Tate, Heather ; Okeke, Iruka N ; Carattoli, Alessandra ; Hsu, Li Yang ; Hopkins, Katie L ; Muloi, Dishon M ; Wheeler, Nicole E ; Aanensen, David M ; Mason, Lewis C E ; Rodgus, Jonah ; Hendriksen, Rene S ; Essack, Sabiha Y ; Egyir, Beverly ; Halpin, Alison L ; MacCannell, Duncan R ; Campos, Josefina ; Srikantiah, Padmini ; Feasey, Nicholas A ; Peacock, Sharon J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-a6de82f205a61324d351962d055ce70aab967e6d4d38cc762889e46884162c653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Anti-Infective Agents</topic><topic>Bacterial Infections - drug therapy</topic><topic>Drug Resistance, Bacterial - genetics</topic><topic>Genomics</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baker, Kate S</creatorcontrib><creatorcontrib>Jauneikaite, Elita</creatorcontrib><creatorcontrib>Nunn, Jamie G</creatorcontrib><creatorcontrib>Midega, Janet T</creatorcontrib><creatorcontrib>Atun, Rifat</creatorcontrib><creatorcontrib>Holt, Kathryn E</creatorcontrib><creatorcontrib>Walia, Kamini</creatorcontrib><creatorcontrib>Howden, Benjamin P</creatorcontrib><creatorcontrib>Tate, Heather</creatorcontrib><creatorcontrib>Okeke, Iruka N</creatorcontrib><creatorcontrib>Carattoli, Alessandra</creatorcontrib><creatorcontrib>Hsu, Li Yang</creatorcontrib><creatorcontrib>Hopkins, Katie L</creatorcontrib><creatorcontrib>Muloi, Dishon M</creatorcontrib><creatorcontrib>Wheeler, Nicole E</creatorcontrib><creatorcontrib>Aanensen, David M</creatorcontrib><creatorcontrib>Mason, Lewis C E</creatorcontrib><creatorcontrib>Rodgus, Jonah</creatorcontrib><creatorcontrib>Hendriksen, Rene S</creatorcontrib><creatorcontrib>Essack, Sabiha Y</creatorcontrib><creatorcontrib>Egyir, Beverly</creatorcontrib><creatorcontrib>Halpin, Alison L</creatorcontrib><creatorcontrib>MacCannell, Duncan R</creatorcontrib><creatorcontrib>Campos, Josefina</creatorcontrib><creatorcontrib>Srikantiah, Padmini</creatorcontrib><creatorcontrib>Feasey, Nicholas A</creatorcontrib><creatorcontrib>Peacock, Sharon J</creatorcontrib><creatorcontrib>SEDRIC Genomics Surveillance Working Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet. Microbe</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baker, Kate S</au><au>Jauneikaite, Elita</au><au>Nunn, Jamie G</au><au>Midega, Janet T</au><au>Atun, Rifat</au><au>Holt, Kathryn E</au><au>Walia, Kamini</au><au>Howden, Benjamin P</au><au>Tate, Heather</au><au>Okeke, Iruka N</au><au>Carattoli, Alessandra</au><au>Hsu, Li Yang</au><au>Hopkins, Katie L</au><au>Muloi, Dishon M</au><au>Wheeler, Nicole E</au><au>Aanensen, David M</au><au>Mason, Lewis C E</au><au>Rodgus, Jonah</au><au>Hendriksen, Rene S</au><au>Essack, Sabiha Y</au><au>Egyir, Beverly</au><au>Halpin, Alison L</au><au>MacCannell, Duncan R</au><au>Campos, Josefina</au><au>Srikantiah, Padmini</au><au>Feasey, Nicholas A</au><au>Peacock, Sharon J</au><aucorp>SEDRIC Genomics Surveillance Working Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evidence review and recommendations for the implementation of genomics for antimicrobial resistance surveillance: reports from an international expert group</atitle><jtitle>The Lancet. Microbe</jtitle><addtitle>Lancet Microbe</addtitle><date>2023-12</date><risdate>2023</risdate><volume>4</volume><issue>12</issue><spage>e1035</spage><epage>e1039</epage><pages>e1035-e1039</pages><issn>2666-5247</issn><eissn>2666-5247</eissn><abstract>Nearly a century after the beginning of the antibiotic era, which has been associated with unparalleled improvements in human health and reductions in mortality associated with infection, the dwindling pipeline for new antibiotic classes coupled with the inevitable spread of antimicrobial resistance (AMR) poses a major global challenge. Historically, surveillance of bacteria with AMR typically relied on phenotypic analysis of isolates taken from infected individuals, which provides only a low-resolution view of the epidemiology behind an individual infection or wider outbreak. Recent years have seen increasing adoption of powerful new genomic technologies with the potential to revolutionise AMR surveillance by providing a high-resolution picture of the AMR profile of the bacteria causing infections and providing real-time actionable information for treating and preventing infection. However, many barriers remain to be overcome before genomic technologies can be adopted as a standard part of routine AMR surveillance around the world. Accordingly, the Surveillance and Epidemiology of Drug-resistant Infections Consortium convened an expert working group to assess the benefits and challenges of using genomics for AMR surveillance. In this Series, we detail these discussions and provide recommendations from the working group that can help to realise the massive potential benefits for genomics in surveillance of AMR.</abstract><cop>England</cop><pmid>37977164</pmid><doi>10.1016/S2666-5247(23)00281-1</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2666-5247 |
ispartof | The Lancet. Microbe, 2023-12, Vol.4 (12), p.e1035-e1039 |
issn | 2666-5247 2666-5247 |
language | eng |
recordid | cdi_proquest_miscellaneous_2891759320 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Anti-Infective Agents Bacterial Infections - drug therapy Drug Resistance, Bacterial - genetics Genomics Humans |
title | Evidence review and recommendations for the implementation of genomics for antimicrobial resistance surveillance: reports from an international expert group |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A57%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evidence%20review%20and%20recommendations%20for%20the%20implementation%20of%20genomics%20for%20antimicrobial%20resistance%20surveillance:%20reports%20from%20an%20international%20expert%20group&rft.jtitle=The%20Lancet.%20Microbe&rft.au=Baker,%20Kate%20S&rft.aucorp=SEDRIC%20Genomics%20Surveillance%20Working%20Group&rft.date=2023-12&rft.volume=4&rft.issue=12&rft.spage=e1035&rft.epage=e1039&rft.pages=e1035-e1039&rft.issn=2666-5247&rft.eissn=2666-5247&rft_id=info:doi/10.1016/S2666-5247(23)00281-1&rft_dat=%3Cproquest_cross%3E2891759320%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2891759320&rft_id=info:pmid/37977164&rfr_iscdi=true |